The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFocusrite Regulatory News (TUNE)

Share Price Information for Focusrite (TUNE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 380.00
Bid: 370.00
Ask: 390.00
Change: 0.00 (0.00%)
Spread: 20.00 (5.405%)
Open: 380.00
High: 380.00
Low: 380.00
Prev. Close: 380.00
TUNE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

PDMR Dealings - amendment

3 Oct 2022 18:12

RNS Number : 6301B
Focusrite PLC
03 October 2022
 

For immediate release

 

An amendment has been made to the RNS announcement number 8706T released on 29 November 2021 at 09:48:53.

The following correction has been made to Tim Dingley's total shareholding in the fourth paragraph. 

The text now reads:

"Following the transaction:

Mr. Dingley will have a beneficial holding of 246,472 Ordinary Shares which represents 0.42% of the current issued share capital."

All other details remain unchanged. The full amended text is show below.

 

 

 

 

PDMR Dealings

FOCUSRITE PLC

Released 09:48:53 29 November 2021

 

RNS Number : 8706T

Focusrite PLC

29 November 2021

 

Focusrite plc

 

("the Company" or "the Group")

 

 PDMR Dealings

Settlement of Share Options

 

Focusrite plc (AIM:TUNE), the global music and audio products company that trades under the Focusrite and Novation brands, announces that on 25 November 2021 Tim Dingley, a Person Discharging Managerial Responsibilities ("PDMRs"), exercised nominal cost options over 15,919 shares granted to him under the Company's Performance Share Plan and acquired ordinary shares of 0.1p each in the Company.

 

The option was granted on 21 November 2018 and became vested and exercisable as from 22 November 2021.

 

The exercise of the option was settled in part by the transfer of 8,437 ordinary shares and in part with a cash payment equal to market value of 7,482 ordinary shares to meet the PDMR's liability to income tax and employee national insurance arising on the exercise of the option.

 

Following the transaction:

Mr. Dingley will have a beneficial holding of 246,472 Ordinary Shares which represents 0.42% of the current issued share capital.

 

The information set out below is provided in accordance with the requirements of Article 19(3) of the Market Abuse Regulation (EU) No 596/2014.

1

Details of the persons discharging managerial responsibilities person closely associated

a)

Name

 Tim Dingley

2

Reason for the notification

a)

Position/status

 Chief Operating Officer

b)

Initial notification /Amendment

 Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Focusrite plc

b)

LEI

213800JJ51KA4LOTF736

4A

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary Shares of 0.1p each in Focusrite plc

Identification code

GB00BSBMW716

b)

Nature of the transaction

Exercise of a nominal cost option under the Focusrite plc Performance Share Plan and acquisition of ordinary shares of 0.1p each in Focusrite plc (or, as to 47% of the vested shares number, cash in lieu of such shares).

c)

Price(s) and volume(s)

 

Price(s)

Volumes

£ 15.92

15,919 (settled in part by the transfer of 8,437 ordinary shares and in part with a cash payment equal to market value of 7,482 ordinary shares to meet the PDMR's liability to income tax and employee national insurance arising on the exercise of the option over 15,919 shares)

 

d)

Aggregated information

- Aggregated volume 

- Price 

Not applicable - single transaction

e)

Date of the transaction

25 November 2021

f)

Place of the transaction

Outside a trading venue

4B

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary Shares of 0.1p each in Focusrite plc

Identification code

GB00BSBMW716

b)

Nature of the transaction

Transfer of shares to Janice Dingley (spouse) for nil consideration

c)

Price(s) and volume(s)

 

Price(s)

Volumes

Nil

8,437

d)

Aggregated information

- Aggregated volume 

- Price 

Not applicable - single transaction

e)

Date of the transaction

25 November 2021

f)

Place of the transaction

Outside a trading venue

 

 

 

-ends-

Focusrite plc:

Tim Carroll (CEO)

+44 1494 462246

Sally McKone (CFO)

+44 1494 462246

Investec Bank plc (Nominated Adviser and Joint Broker)

+44 (0) 20 7597 5970

David Flin

William Brinkley

Charlotte Young

Peel Hunt LLP (Joint Broker)

+44 (0) 20 7418 8900

Edward Knight

 

Michael Burke

 

James Smith

 

Belvedere Communications

John West

+44 20 3687 2753

Llew Angus

+44 20 3687 2754

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUPGBUUUPPGMW
Date   Source Headline
25th Mar 20194:44 pmRNSGrant of Share Options to PDMR
19th Mar 20194:42 pmRNSTR-1
19th Mar 20197:00 amRNSTrading Update
11th Mar 20198:36 amRNSTR-1
28th Feb 20196:15 pmRNSTR-1
8th Feb 20197:00 amRNSNotification of transaction by PDMR
7th Feb 201910:32 amRNSHolding(s) in Company
6th Feb 20191:38 pmRNSHolding(s) in Company
28th Jan 20199:36 amRNSHolding(s) in Company
24th Jan 20192:57 pmRNSCompletion of Secondary Placing of Shares
24th Jan 20197:00 amRNSProposed Secondary Placing of Shares
21st Dec 201812:20 pmRNSResult of 2018 Annual General Meeting
21st Dec 20187:00 amRNSAGM Statement and Update on Trading
14th Dec 201810:14 amRNSDirectors' Dealings
4th Dec 20187:00 amRNSExercise of Share Options
3rd Dec 20183:12 pmRNSExercise of Share Options by a PDMR
26th Nov 20183:36 pmRNSGrant of Share Options to Directors
23rd Nov 201812:34 pmRNSDirector/PDMR Shareholding
23rd Nov 201812:29 pmRNSDirector/PDMR Shareholding
20th Nov 20187:00 amRNSFinal Results for the Year Ended 31 August 2018
8th Nov 20184:12 pmRNSHolding(s) in Company
18th Sep 20187:00 amRNSTrading Update
27th Jul 20189:45 amRNSTR-1
3rd Jul 201810:53 amRNSTR-1
29th May 20187:00 amRNSAppointment of Non-executive director
18th May 20185:06 pmRNSHolding(s) in Company
8th May 20189:31 amRNSDirector/PDMR Shareholding
3rd May 201812:18 pmRNSHolding(s) in Company
24th Apr 20187:00 amRNSHalf Year Results
9th Mar 20183:45 pmRNSDirector/PDMR Shareholding
9th Mar 20187:00 amRNSTrading Update
29th Jan 20183:38 pmRNSTR-1
29th Jan 201811:27 amRNSDirector/PDMR Shareholding
18th Jan 20187:00 amRNSDirector/PDMR Shareholding
10th Jan 20183:02 pmRNSResult of 2018 AGM
10th Jan 20187:00 amRNSAGM Statement and Update on Trading
19th Dec 20177:00 amRNSDirector/PDMR Shareholding
19th Dec 20177:00 amRNSDirector/PDMR Shareholding
15th Dec 20174:02 pmRNSDirector's Dealings
14th Dec 20179:56 amRNSDirector/PDMR Shareholding
5th Dec 201712:56 pmRNSTR-1: Standard form
30th Nov 20176:14 pmRNSCompletion of Secondary Placing of Shares
30th Nov 20174:35 pmRNSProposed Secondary Placing of Shares
24th Nov 20174:24 pmRNSPDMR Shareholding
23rd Nov 201710:22 amRNSPDMR Grant of Share Options
23rd Nov 201710:21 amRNSDirector's Dealings
23rd Nov 20177:00 amRNSDirector Share Dealings - Replacement
22nd Nov 20172:50 pmRNSDirector Share Dealings
21st Nov 20177:00 amRNSFinal Results for the Year Ended 31 August 2017
20th Sep 20172:54 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.